Macular telangiectasia (sometimes called idiopathic juxtafoveal telangiectasis or MacTel) is a disease that affects the macula. That's the part of your eye that allows you to see things directly in ...

Affecting the nervous system, immune system and other body organs, ataxia telangiectasia is characterized with uncoordinated movements of the individual suffering from this disorder. The secondary ...

Hereditary hemorrhagic telangiectasia (HHT) can cause recurrent, severe epistaxis, as well as anemia and reduced quality of ...

HealthDay News — For adult patients with hereditary hemorrhagic telangiectasia (HHT), a new, allosteric, selective activin receptor-like kinase 1 inhibitor, oral engasertib, is safe and is associated ...

Hereditary hemorrhagic telangiectasia, or Osler–Weber–Rendu syndrome, is an autosomal dominant vascular disorder that affects multiple systems. It is characterized by skin and mucosal telangiectasias ...

FXS0887为复星医药自主研发的一款口服小分子创新药物，拟用于晚期恶性实体瘤的治疗，可特异性抑制ATR（Ataxia Telangiectasia and Rad3-related）激酶活性，通过干预细胞周期调控和DNA损伤修复相关通路，从而抑制肿瘤细胞的恶性增殖。截至目前的临床前研究显示，该新药在多种类型肿瘤模型中表现出良好的抗肿瘤活性，脱靶风险较小，安全性良好。

A 39-year-old right-handed man presented to his family physician with sudden-onset weakness in his right arm and leg that had lasted 10 minutes and resolved completely. In the year before presentation ...

Quince Therapeutics has dosed the first subject in its Phase III NEAT clinical trial of EryDex for the treatment of Ataxia-Telangiectasia (A-T), an inherited neurodegenerative and immunodeficiency ...

Engasertib is the first to be specifically developed for hereditary hemorrhagic telangiect ...